Ultrasonic Backscatter Imaging for ACL Reconstruction and Shoulder Diseases
Launched by CHANG GUNG MEMORIAL HOSPITAL · Apr 7, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new imaging technology called Nakagami imaging, which uses ultrasound to assess soft tissues like tendons and ligaments in people undergoing surgery for ACL (anterior cruciate ligament) injuries or those with shoulder problems. The goal is to improve how doctors diagnose and evaluate these conditions by providing clearer and more precise information about the tissue's health. This technology aims to offer a better understanding of injuries and help in creating consistent guidelines for diagnosis and treatment.
To participate in this study, you need to be an adult aged 20 or older. If you have issues with your shoulder tendons, ligaments, or nerves, you could be part of the group being studied. There is also a control group for comparison, which includes individuals of similar age and gender who do not have these issues. Participants will undergo ultrasound exams and may help researchers understand how well this new imaging technique works. This study could lead to faster and better treatment options for patients with musculoskeletal injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 20 and above
- • Experimental group: Individuals with tendon, ligament, or nerve disorders around the shoulder joint
- • Control group: Individuals with similar age and gender as the experimental group, confirmed by ultrasound and MRI to have no known diseases of the shoulder tendons, ligaments, or nerves
- Exclusion Criteria:
- • Individuals with a history of injury or disease in the area to be tested: such as fractures, tendon, ligament, or nerve disorders
- • Vulnerable groups: such as pregnant women, children, individuals with mental illness, inmates, etc.
- • Individuals who cannot communicate in Chinese
- • Individuals with poor compliance or obvious mental status abnormalities, or for any reason unable to cooperate with completing clinical symptom interviews, physical examinations, ultrasound examinations, etc.
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported